TheraCryf CEO Dr Huw Jones on Positive OX-1 Toxicology Results, Partner Interest & Human Trials

By London South East / May 15, 2026 / www.youtube.com / Article Link


TheraCryf plc (TCF) is a biotechnology company developing novel treatments for addiction and other neuropsychiatric disorders.

Recent News

Most major producers and TSXV gold have major gains
November 09, 2026 / www.canadianminingreport.com

Gold stocks rebound as metal price jumps
November 09, 2026 / www.canadianminingreport.com

Big Gold Q3/26 strong results continue
November 02, 2026 / www.canadianminingreport.com

Gold stocks decline as major sector rotation continues
November 02, 2026 / www.canadianminingreport.com

Gold stocks slump in global sector rotation
October 26, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok